CLINICAL SUPPLY PACKAGING ARTICLES
AI In Clinical Supply – Hype, Hope, And The Path To Predictive Precision
Agentic AI offers new hope for predictive precision in clinical supply, but success will depend on data readiness, connected systems, and maintaining human oversight.
CLINICAL SUPPLY PACKAGING RESOURCES
-
Review current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.
-
Adopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.
-
One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?
-
Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.
-
Learn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.
-
Explore how strategic, integrated packaging can accelerate clinical-to-commercial success while enabling patient-centric, scalable, and globally resilient drug delivery.
-
Learn how this biopharmaceutical research sponsor was able to centralize and digitalize the processes involved in clinical supply production through distribution using GxP Inventory.